Provided by Tiger Trade Technology Pte. Ltd.

AxoGen

30.78
-0.3800-1.22%
Post-market: 30.780.00000.00%19:32 EDT
Volume:1.64M
Turnover:50.71M
Market Cap:1.60B
PE:-90.26
High:31.47
Open:31.38
Low:30.65
Close:31.16
52wk High:36.00
52wk Low:9.22
Shares:51.90M
Float Shares:45.24M
Volume Ratio:1.58
T/O Rate:3.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3410
EPS(LYR):-0.3410
ROE:-13.49%
ROA:-2.31%
PB:12.40
PE(LYR):-90.26

Loading ...

AxoGen's prelim Q4 revenue beats expectations on strong portfolio performance

Reuters
·
Jan 12

Axogen Projects 2025 Revenue to Rise 20% to $225 Million

Reuters
·
Jan 12

AxoGen Inc - Full-Year 2025 Revenue Expected at $225.2 Mln, up 20.2% YoY

THOMSON REUTERS
·
Jan 12

AxoGen Inc FY2025 REV View $223.3 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
Jan 12

AxoGen Inc - Q4 2025 Revenue Expected at $59.9 Mln, up 21.3% YoY

THOMSON REUTERS
·
Jan 12

AxoGen Inc Q4 REV View $58.0 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
Jan 12

AxoGen Q4 Revenue USD 59.9 Million VS. Ibes Estimate USD 57.8 Million

THOMSON REUTERS
·
Jan 12

Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025

GlobeNewswire
·
Jan 12

Axogen, Inc. (NASDAQ:AXGN) Could Be Less Than A Year Away From Profitability

Simply Wall St.
·
Jan 03

Axogen CFO Lindsey Marie Hartley Reports Disposal of Common Shares

Reuters
·
Dec 18, 2025

Axogen Inc. to Present at J.P. Morgan 2026 Healthcare Conference

Reuters
·
Dec 17, 2025

Axogen EVP and General Counsel Marc A. Began Reports Sale of Common Shares

Reuters
·
Dec 13, 2025

Trade Alert: President Of Axogen Michael Dale Has Sold Stock

Simply Wall St.
·
Dec 12, 2025

Axogen Chief Marketing Officer Jens Kemp Reports Sale of Common Shares

Reuters
·
Dec 11, 2025

Axogen (AXGN): Reassessing Valuation After FDA Biologics License Approval for AVANCE

Simply Wall St.
·
Dec 07, 2025

Axogen Inc. Raises CFO Lindsey Hartley’s Salary and Bonus Target

Reuters
·
Dec 06, 2025

Axogen Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Dec 06, 2025

Three Stocks Estimated To Be Trading Below Intrinsic Value In December 2025

Simply Wall St.
·
Dec 06, 2025

AxoGen, Inc. : H.c. Wainwright Raises Target Price to $39 From $26

THOMSON REUTERS
·
Dec 05, 2025

U.S. RESEARCH ROUNDUP- American Tower, CME Group, Ulta Beauty

Reuters
·
Dec 05, 2025